Skeletal muscle phosphodiester content relates to body mass and glycemic control

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Szendroedi, Julia ^a,b   Schmid, Albrecht Ingo ^b   Chmelik, Marek ^b   Krssak, Martin ^b   Nowotny, Peter ^a,b   Prikoszovich, Thomas ^b   Kautzky Willer, Alexandra ^b   Wolzt, Michael ^b   Waldhäusl, Werner ^b   Roden, Michael ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; PHOSPHODIESTER; PHOSPHOLIPID; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UNCLASSIFIED DRUG; ORGANOPHOSPHATE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; SKELETAL MUSCLE; AGED; BLOOD; BODY COMPOSITION; CASE CONTROL STUDY; DIET RESTRICTION; METABOLISM; MIDDLE AGED; MITOCHONDRION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY;

ADULT; AGED; BLOOD GLUCOSE; BODY COMPOSITION; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; INSULIN RESISTANCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MITOCHONDRIA; MUSCLE, SKELETAL; PHOSPHORIC ACID ESTERS;

EID: 79960321871     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021846     Document Type: Article

References (55)

1. Phielix E, Szendroedi J, Roden M, (2010) Mitochondrial Function and Insulin Resistance during Aging- A Mini-Review. Gerontology.
2. Lowell BB, Shulman GI, (2005) Mitochondrial dysfunction and type 2 diabetes. Science 307: 384-387.
3. Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, et al. (2007) Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 50: 113-120.
4. Phielix E, Schrauwen-Hinderling VB, Mensink M, Lenaers E, Meex R, et al. (2008) Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes 57: 2943-2949.
5. Lee HY, Choi CS, Birkenfeld AL, Alves TC, Jornayvaz FR, et al. (2010) Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metab 12: 668-674.
6. Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, et al. (2009) Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest.
7. Holloszy JO, (2009) Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance. Am J Clin Nutr 89: 463S-466S.
8. Karakelides H, Irving BA, Short KR, O'Brien P, Nair KS, (2009) Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes.
9. Boschmann M, Engeli S, Moro C, Luedtke A, Adams F, et al. (2010) LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance. J Clin Endocrinol Metab 95: 1634-1643.
10. Velho G, Byrne MM, Clement K, Sturis J, Pueyo ME, et al. (1996) Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation. Diabetes 45: 478-487.
11. Szendroedi J, Ingo Schmid A, Meyerspeer M, Cervin C, Kacerovsky M, et al. (2009) Impaired mitochondrial function and insulin resistance of skeletal muscle in mitochondrial diabetes. Diabetes Care.
12. Cox IJ, Menon DK, Sargentoni J, Bryant DJ, Collins AG, et al. (1992) Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques. J Hepatol 14: 265-275.
13. Matthews PM, Allaire C, Shoubridge EA, Karpati G, Carpenter S, et al. (1991) In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease. Neurology 41: 114-120.
14. Edwards RH, Dawson MJ, Wilkie DR, Gordon RE, Shaw D, (1982) Clinical use of nuclear magnetic resonance in the investigation of myopathy. Lancet 1: 725-731.
15. Younkin DP, Berman P, Sladky J, Chee C, Bank W, et al. (1987) 31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes. Neurology 37: 165-169.
16. Satrustegui J, Berkowitz H, Boden B, Donlon E, McLaughlin A, et al. (1988) An in vivo phosphorus nuclear magnetic resonance study of the variations with age in the phosphodiester content of human muscle. Mech Ageing Dev 42: 105-114.
17. Slade JM, Delano MC, Meyer RA, (2006) Elevated skeletal muscle phosphodiesters in adults using statin medications. Muscle Nerve 34: 782-784.
18. Taylor DJ, Kemp GJ, Thompson CH, Radda GK, (1997) Ageing: effects on oxidative function of skeletal muscle in vivo. Mol Cell Biochem 174: 321-324.
19. Lanza IR, Nair KS, (2010) Mitochondrial function as a determinant of life span. Pflugers Arch 459: 277-289.
20. Waters DL, Brooks WM, Qualls CR, Baumgartner RN, (2003) Skeletal muscle mitochondrial function and lean body mass in healthy exercising elderly. Mech Ageing Dev 124: 301-309.
21. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, et al. (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300: 1140-1142.
22. Szendroedi J, Schmid AI, Chmelik M, Toth C, Brehm A, et al. (2007) Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med 4: e154.
23. Prikoszovich T, Winzer C, Schmid AI, Szendroedi J, Chmelik M, et al. (2010) Body and Liver Fat Mass Rather Than Muscle Mitochondrial Function Determines Glucose Metabolism in Women with a History of Gestational Diabetes. Diabetes Care.
24. Burt CT, Glonek T, Barany M, (1976) Phosphorus-31 nuclear magnetic resonance detection of unexpected phosphodiesters in muscle. Biochemistry 15: 4850-4853.
25. Brown TR, Ugurbil K, Shulman RG, (1977) 31P nuclear magnetic resonance measurements of ATPase kinetics in aerobic Escherichia coli cells. Proc Natl Acad Sci U S A 74: 5551-5553.
26. Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, et al. (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42: 113-116.
27. Mandarino LJ, Consoli A, Jain A, Kelley DE, (1993) Differential regulation of intracellular glucose metabolism by glucose and insulin in human muscle. Am J Physiol 265: E898-905.
28. Hother-Nielsen O, Vaag A, Skott P, Beck-Nielsen H, (1993) Effect of hyperglycemia per se on glucose turnover rates in patients with insulin-dependent diabetes. Metabolism 42: 86-93.
29. Jubrias SA, Bennett RM, Klug GA, (1994) Increased incidence of a resonance in the phosphodiester region of 31P nuclear magnetic resonance spectra in the skeletal muscle of fibromyalgia patients. Arthritis Rheum 37: 801-807.
30. Hug F, Bendahan D, Le Fur Y, Cozzone PJ, Grelot L, (2005) Metabolic recovery in professional road cyclists: a 31P-MRS study. Med Sci Sports Exerc 37: 846-852.
31. Bernus G, Gonzalez de Suso JM, Alonso J, Martin PA, Prat JA, et al. (1993) 31P-MRS of quadriceps reveals quantitative differences between sprinters and long-distance runners. Med Sci Sports Exerc 25: 479-484.
32. Burt CT, Pluskal MG, Sreter FA, (1982) Generation of phosphodiesters during fast-to-slow muscle transformation. A 31P-NMR study. Biochim Biophys Acta 721: 492-494.
33. Oberbach A, Bossenz Y, Lehmann S, Niebauer J, Adams V, et al. (2006) Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes. Diabetes Care 29: 895-900.
34. Hickey MS, Carey JO, Azevedo JL, Houmard JA, Pories WJ, et al. (1995) Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am J Physiol 268: E453-457.
35. Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE, (1999) Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. Faseb J 13: 2051-2060.
36. Kelley DE, Simoneau JA, (1994) Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 94: 2349-2356.
37. He J, Watkins S, Kelley DE, (2001) Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 50: 817-823.
38. Hebert SL, Lanza IR, Nair KS, (2010) Mitochondrial DNA alterations and reduced mitochondrial function in aging. Mech Ageing Dev 131: 451-462.
39. Kelley DE, He J, Menshikova EV, Ritov VB, (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51: 2944-2950.
40. Ritov VB, Menshikova EV, Azuma K, Wood R, Toledo FG,et al. Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am J Physiol Endocrinol Metab 298: E49-58.
41. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, et al. (2007) Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50: 790-796.
42. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI, (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664-671.
43. Hey-Mogensen M, Hojlund K, Vind BF, Wang L, Dela F, et al. (2010) Effect of physical training on mitochondrial respiration and reactive oxygen species release in skeletal muscle in patients with obesity and type 2 diabetes. Diabetologia 53: 1976-1985.
44. Sleigh A, Raymond-Barker P, Thackray K, Porter D, Hatunic M, et al. (2011) Mitochondrial dysfunction in patients with primary congenital insulin resistance. J Clin Invest.
45. Lefort N, Glancy B, Bowen B, Willis WT, Bailowitz Z, et al. (2010) Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle. Diabetes 59: 2444-2452.
46. Pospisilik JA, Knauf C, Joza N, Benit P, Orthofer M, et al. (2007) Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 131: 476-491.
47. Nair KS, Bigelow ML, Asmann YW, Chow LS, Coenen-Schimke JM, et al. (2008) Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes 57: 1166-1175.
48. Schunk K, Pitton M, Duber C, Kersjes W, Schadmand-Fischer S, et al. (1999) Dynamic phosphorus-31 magnetic resonance spectroscopy of the quadriceps muscle: effects of age and sex on spectroscopic results. Invest Radiol 34: 116-125.
49. Kemp GJ, (2008) The interpretation of abnormal 31P magnetic resonance saturation transfer measurements of Pi/ATP exchange in insulin-resistant skeletal muscle. Am J Physiol Endocrinol Metab 294: E640-642 author reply E643-644.
50. Pan DA, Lillioja S, Milner MR, Kriketos AD, Baur LA, et al. (1995) Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest 96: 2802-2808.
51. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, et al. (1996) Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97: 2859-2865.
52. Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, et al. (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5: 167-179.
53. Itani SI, Ruderman NB, Schmieder F, Boden G, (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51: 2005-2011.
54. Ristow M, Zarse K, Oberbach A, Kloting N, Birringer M, et al. (2009) Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A 106: 8665-8670.
55. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358: 2560-2572.